Stein, C. S., Kang, Y., Sauter, S. L., Townsend, K., Staber, P., Derken, T. A., … McCray, P. B. (2001). In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using non-primate lentiviral vectors. Molecular Therapy, 3, 850–856.

Stein, C. S., Y. Kang, S. L. Sauter, K. Townsend, P. Staber, T. A. Derken, I. Martins, J. Qian, B. L. Davidson, and P. B. McCray. “In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using non-primate lentiviral vectors.” Molecular Therapy 3 (2001): 850–56.

Stein CS, Kang Y, Sauter SL, Townsend K, Staber P, Derken TA, et al. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using non-primate lentiviral vectors. Molecular Therapy. 2001;3:850–6.

Stein, C. S., et al. “In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using non-primate lentiviral vectors.” Molecular Therapy, vol. 3, Nature Publishing Group: Open Access Hybrid Model Option B, 2001, pp. 850–56.

Stein CS, Kang Y, Sauter SL, Townsend K, Staber P, Derken TA, Martins I, Qian J, Davidson BL, McCray PB. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using non-primate lentiviral vectors. Molecular Therapy. Nature Publishing Group: Open Access Hybrid Model Option B; 2001;3:850–856.